This study not only reveals the pathological role of TRIM44 in NSCLC, but also suggests that it could be used as a prognostic factor and therapeutic target in NSCLC and, possibly, other cancers as well. This evidence concerns the gene TRIM44 and non-small cell lung carcinoma.